Japan’s vaccine rollout is set to start in less than two weeks. But with the rollout in other countries, including the U.S., not going as smoothly as authorities would have wanted, there are worries that it could be chaotic for Japan, too.
The rollout in Japan is the last among the Group of Seven nations, with the health ministry set to formally approve U.S. drugmaker Pfizer Inc.’s mRNA vaccine, developed jointly with Germany’s BioNTech SE, on Feb. 15. The start of vaccinations for medical professionals will follow two days later, local reports say.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.